BillionToOne is trading 4.2% up at $118.83 on October 28, 2026, amid biotech-sector strength, though no direct cause is established. - The provided sector update shows XBI up 2.18%, amid positive clinical and regulatory news across other companies. - BillionToOne’s next quarterly results are scheduled for November 4. - Its latest investor-conference announcement concerns events in November.